TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

NCT02574663 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer
Colorectal Cancer
Rectal Cancer
Gastric Cancer
Esophageal Cancer
Gastrointestinal Stromal Tumor (GIST)

Interventions

DRUG: TGR-1202
DRUG: nab-paclitaxel + gemcitabine
DRUG: Oxaliplatin + Folinic acid + Fluorouracil
DRUG: Oxaliplatin + Folinic acid + Fluorouracil + Bevacizumab

Sponsor

TG Therapeutics, Inc.

Collaborators

[object Object]